SCHEMBL6602079

SCHEMBL6602079

Cc1cc(/N=C(\N)c2cccs2)ccc1N1CCN(C(=O)O)CC1

nearest known ligand 0.56

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 15/20 0.49
NOS1 P29475 17/20 0.48
NOS2 P35228 12/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6602083 1.00 NOS3 (0.49) NOS3NOS1NOS2
SCHEMBL5394569 0.87 NOS3 (0.45) NOS3NOS1NOS2
SCHEMBL5394567 0.87 NOS3 (0.45) NOS3NOS1NOS2
SCHEMBL6602318 0.84 NOS1 (0.58) NOS3NOS1NOS2
SCHEMBL6602315 0.84 NOS1 (0.58) NOS3NOS1NOS2
Hydrochloric Acid SCHEMBL5385359 0.83 NOS1 (0.58) NOS3NOS1NOS2
Hydrochloric Acid SCHEMBL5385353 0.83 NOS1 (0.58) NOS3NOS1NOS2
SCHEMBL6598976 0.82 NOS1 (0.56) NOS3NOS1
SCHEMBL6598979 0.82 NOS1 (0.56) NOS3NOS1
SCHEMBL6600980 0.81 NOS1 (0.52) NOS3NOS1NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1265891-B1 NOVEL LIPOIC ACID HETEROCYCLIC OR BENZENE DERIVATIVES, PREPARATION AND USE THEREOF AS MEDICINES CONSEILS DE RECH SET D APPLIC (FR) 2004-12-29 EP disclosed
EP-1265891-A2 NOVEL LIPOIC ACID HETEROCYCLIC OR BENZENE DERIVATIVES, PREPARATION AND USE THEREOF AS MEDICINES SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2002-12-18 EP disclosed
WO-2001068643-A2 NOVEL LIPOIC ACID HETEROCYCLIC OR BENZENE DERIVATIVES, PREPARATION AND USE THEREOF AS MEDICINES SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2001-09-20 WO disclosed